• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Teva Pharma`s Generics Azilsartan Medoxomil Receives Tentative Approval in US

    06 Aug 2024 //

    FDA

    Zydus Lifesciences gets tentative approval from USFDA for BP lowering drug

    05 Jul 2024 //

    ECONOMIC TIMES

    Zydus Pharms USA Generic Azilsartan Medoxomil Receives Tentative Approval in US

    12 Jun 2024 //

    FDA

    Alkem`s Generic Azilsartan Medoxomil, Chlorthalidone Receives Approval in the U.S.

    28 Nov 2023 //

    FDA

    Lupin receives approval from USFDA for hypertension tablets

    26 Jul 2022 //

    ET HEALTH

    Lupin Ltd Generic Azilsartan Kamedoxomil Receives Approval in the U.S.

    20 Jul 2022 //

    FDA

    FDA Confirms Paragraph IV Patent Litigation for Aprepitant, Azilsartan, Bupivacaine, Cladribine, Elrombopag, Fosnetupitant, Fostamatinib, Ivacaftor and Sodium Thiosulfate.

    13 Jun 2022 //

    FDA

    FDA Confirms Paragraph IV Patent Litigation for Azilsartan Medoxomil and Chlorthalidomide

    13 Jun 2022 //

    FDA

    Lupin receives US FDA approval for generic Edarbi tablets

    24 Dec 2021 //

    PHARMABIZ

    Lupin receives US FDA approval for generic Edarbi tablets

    24 Dec 2021 //

    PHARMABIZ

    FDA Confirms Paragraph IV Patent Challenge of Edarbi 200796(Azilsartan Kamedoxomil) Tablets 40 mg and 80 mg

    03 Jun 2020 //

    FDA

    FDA presents interim limits of nitrosamines in currently marketed ARBs

    21 Dec 2018 //

    FDA

    India’s drug regulatory force conducts third round of raids on manufacturers

    02 May 2018 //

    FIERCE PHARMA

    Japanese Companies Make Cautious Return to Indian Pharma Market

    04 Jan 2017 //

    ECONOMIC TIMES

    FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex`s Kaldeco

    11 Mar 2015 //

    RAPS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.